Literature DB >> 461224

Lung biopsy: methods, value, complications, timing, and indications.

P Dalquen, M Oberholzer.   

Abstract

Six methods of lung biopsy are discussed on the basis of literature reports: 1. Aspiration biopsy by fine needle, 2. split needle biopsy (Vim-Silverman), 3. cutting needle biopsy (Travenol), 4. trephine biopsy by rotating needle, 5. transbronchial biopsy, 6. open biopsy. Because of the high risk, biopsies with thick needles (methods 2--4) should be abandoned. Transbronchial biopsy is renounced because reliable results are only achieved in sarcoidosis which can be clearly diagnosed in high percentage of cases by other less dangerous procedures. In solitary tumors which could not be diagnosed by any other means aspiration biopsy is indicated because of its low risk and its diagnostic accuracy of more than 80%. In disseminated pulmonary disorders which cannot be diagnosed by any other means open lung biopsy is the most reliable method. The lung specimens can be taken under eye control. They should contain tissue from the transitional zone between diseased and unchanged areas, however. The specimens are usually big enough for additional electron and fluorescence microscopic examinations as well as dust analyses. The pathologist must be aware of all clinical data including X-ray pictures, laboratory findings, case history, and history of occupational and nonoccupational dust exposure. If these conditions are fulfilled and adequate methods are applied, lung biopsy provides diagnosis and prognosis, makes causal therapy possible, and amplifies the medical knowledge of pulmonary diseases.

Entities:  

Mesh:

Year:  1979        PMID: 461224     DOI: 10.1016/S0344-0338(79)80097-7

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  1 in total

1.  Advantages of multidetector-row CT with multiplanar reformation in guiding percutaneous lung biopsies.

Authors:  M De Filippo; M Onniboni; M Rusca; P Carbognani; L Ferrari; A Guazzi; A Casalini; E Verardo; V Cataldi; M Tiseo; N Sverzellati; G Chiari; E Rabaiotti; A Corsi; G Cacciani; M Sommario; A Ardizzoni; M Zompatori
Journal:  Radiol Med       Date:  2008-09-25       Impact factor: 3.469

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.